PURPOSE: The current study was designed to identify prognostic factors for long-term survival in patients with advanced colorectal cancer in a consecutive cohort. METHODS: A total of 123 patients were operated because of T4 colorectal cancer between 1 January 2002 and 31 December 2008 in the Clinic of Surgery, UK-SH Campus Luebeck. RESULTS: A total of 78 patients underwent a multivisceral resection. The postoperative morbidity was elevated in the patient group with multivisceral resections (34.6% vs. 26.7%). Nevertheless, we detected no significant differences concerning 30 days mortality (7.7% vs. 8.9%; p = 0.815). The main prognostic factor that reached significance in the multivariate analysis was the possibility to obtain a R0 resection (p < 0.0001) resulting in a 5-year survival rate of 55% for patients with curative resection. There were no statistically significant differences in 5-year survival between multivisceral and non-multivisceral resections (p = 0.608). Also we were not able to detect any significant differences for cancer of colonic or rectal origin (p = 0.839), for laparoscopic vs. open procedures (p = 0.610), and for emergency vs. planned operations (p = 0.674). Moreover, the existence of lymph node metastases was not a predictive factor concerning survival as there was no difference between patients with and without lymph node metastases (p = 0.658). CONCLUSIONS: Multivisceral resections are associated with the same 5-year survival as standard resections. Therefore, the aim to perform a R0 resection should always be the main goal in surgery for colorectal cancer. In planned operations, a laparoscopic approach is justified in selected patients.
PURPOSE: The current study was designed to identify prognostic factors for long-term survival in patients with advanced colorectal cancer in a consecutive cohort. METHODS: A total of 123 patients were operated because of T4 colorectal cancer between 1 January 2002 and 31 December 2008 in the Clinic of Surgery, UK-SH Campus Luebeck. RESULTS: A total of 78 patients underwent a multivisceral resection. The postoperative morbidity was elevated in the patient group with multivisceral resections (34.6% vs. 26.7%). Nevertheless, we detected no significant differences concerning 30 days mortality (7.7% vs. 8.9%; p = 0.815). The main prognostic factor that reached significance in the multivariate analysis was the possibility to obtain a R0 resection (p < 0.0001) resulting in a 5-year survival rate of 55% for patients with curative resection. There were no statistically significant differences in 5-year survival between multivisceral and non-multivisceral resections (p = 0.608). Also we were not able to detect any significant differences for cancer of colonic or rectal origin (p = 0.839), for laparoscopic vs. open procedures (p = 0.610), and for emergency vs. planned operations (p = 0.674). Moreover, the existence of lymph node metastases was not a predictive factor concerning survival as there was no difference between patients with and without lymph node metastases (p = 0.658). CONCLUSIONS: Multivisceral resections are associated with the same 5-year survival as standard resections. Therefore, the aim to perform a R0 resection should always be the main goal in surgery for colorectal cancer. In planned operations, a laparoscopic approach is justified in selected patients.
Authors: Hermann Brenner; Anne Marie Bouvier; Roberto Foschi; Monika Hackl; Inger Kristin Larsen; Valery Lemmens; Lucia Mangone; Silvia Francisci Journal: Int J Cancer Date: 2011-08-03 Impact factor: 7.396
Authors: Roland S Croner; Susanne Merkel; Thomas Papadopoulos; Vera Schellerer; Werner Hohenberger; Jonas Goehl Journal: Dis Colon Rectum Date: 2009-08 Impact factor: 4.585
Authors: Amir Darakhshan; Betty P F C Lin; Charles Chan; Pierre H Chapuis; Owen F Dent; Les Bokey Journal: Ann Surg Date: 2008-04 Impact factor: 12.969
Authors: George Z Li; Ryan S Turley; Michael E Lidsky; Andrew S Barbas; Srinevas K Reddy; Bryan M Clary Journal: J Gastrointest Surg Date: 2012-06-28 Impact factor: 3.452
Authors: Piera Leon; Michele Giuseppe Iovino; Fabiola Giudici; Antonio Sciuto; Nicolò de Manzini; Diego Cuccurullo; Francesco Corcione Journal: Surg Endosc Date: 2017-08-25 Impact factor: 4.584
Authors: E Schloericke; M Zimmermann; C Benecke; T Laubert; R Meyer; H-P Bruch; R Bouchard; T Keck; M Hoffmann Journal: Tech Coloproctol Date: 2017-12-01 Impact factor: 3.781
Authors: Quentin Denost; Florence Saillour; Lindy Masya; Helene Maillou Martinaud; Stephanie Guillon; Marion Kret; Eric Rullier; Bruno Quintard; Michael Solomon Journal: BMC Cancer Date: 2016-04-04 Impact factor: 4.430